Halder Venture Approves Auditor Changes, Capital Increase, and Warrant Issue
Halder Venture's Board approved auditor changes, a capital increase from ₹13.43 crore to ₹18.43 crore, and the issuance of 7,93,650 convertible warrants at ₹315 each to specified entities, including P.K. Bio Link Private Limited for ₹25 crore. Shareholder approval via postal ballot is required.
The issuance of warrants and increase in authorized capital are significant financial events that could impact the company's capital structure and future growth. The change in auditors is a routine corporate action.
The company is undertaking several positive corporate actions including fundraising through warrants and increasing its authorized share capital, which indicates growth and expansion plans. Appointment of new auditors is a routine but necessary step.
Halder Venture Limited's Board of Directors, in a meeting held on March 26, 2026, approved several key resolutions. The board accepted the resignation of M/s Somnath Ray & Associates as Internal Auditor due to preoccupation and approved the appointment of M/s J Kumar Jain & Associates as the new Internal Auditor for the Financial Year 2025-2026.
Furthermore, the board consented to an increase in the company's authorized share capital, subject to shareholder approval via postal ballot. This includes creating and issuing up to 7,93,650 convertible warrants, each with a face value of ₹10 and an issue price of ₹315, convertible into one fully paid-up equity share. These warrants will be offered to specified persons/entities, including P.K. Bio Link Private Limited, which plans to subscribe to 7,93,650 warrants for ₹24,99,99,750. The company also approved a postal ballot notice to seek shareholder consent for these proposals.
The authorized share capital will be increased from ₹13,42,50,000 to ₹18,42,50,000 by creating an additional 50,00,000 equity shares of ₹10 each. This necessitates consequential changes to Clause V of the Memorandum of Association.
What to do with a filing like this
Halder Venture Limited filed this with the NSE as a statutory disclosure, categorised under auditor changes. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Halder Venture Limited. Read the original for the full detail.